Actively Recruiting

Phase Not Applicable
Age: 5Years - 12Years
All Genders
ID06831396

Communication in Children With or Without Biomedical Conditions: Speech and Language Profile, Related Outcomes and Articulation Treatment With Ultrasound

Led by The University of Hong Kong · Updated on 2026-03-10

60

Participants Needed

1

Research Sites

8 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are investigating the use of ultrasound visual biofeedback as an addition to articulation therapy for children aged 5 to 12 with speech sound disorders involving tongue movements. This study aims to help children better learn to pronounce difficult sounds by allowing them to see real-time images of their tongue during speech. Participants are randomly assigned to either receive immediate treatment or be placed on a wait-list control group that receives usual care initially, then later the same ultrasound therapy. The intervention being studied is a motor-phonetic approach enhanced by ultrasound visual biofeedback, which helps children visualize their tongue movements to improve speech sounds. Children in the immediate treatment group receive this therapy right away, while those in the wait-list control group receive no treatment for 4 weeks before crossing over to get the same ultrasound therapy. This design allows comparison of outcomes between groups while ensuring all participants eventually receive the treatment. Participants will be evaluated at multiple points including baseline, 4, 8, and 16 weeks. Researchers will measure speech accuracy using a 20-item probe list, speech intelligibility, consonant correctness, quality of life, behavioral strengths and difficulties, and parental stress. These assessments include questionnaires and speech evaluations. The study involves double-blind randomization and continues until 16 weeks with follow-up visits to monitor progress and outcomes.

CONDITIONS

Brief Title

Effectiveness of Ultrasound-Aided Articulation Therapy for Children With Speech Sound Disorders

Who Can Participate

Age: 5Years - 12Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Primary diagnosis of speech sound disorder with errors on lingual target sounds
  • Probe accuracy less than 70% on the primary target sound at baseline
  • Cantonese as the first language
  • Hearing thresholds 25 dB or less in at least one ear, with no hearing loss exceeding 50 dB in the other ear
  • No syndromes or obvious dysmorphic features
  • No language disorders associated with biomedical conditions (e.g., cerebral palsy, autism spectrum disorder)
  • No oronasal fistula identified on oral examination or diagnosed velopharyngeal insufficiency
Not Eligible

You will not qualify if you...

  • Presence of syndromes or dysmorphic features
  • Language disorder associated with biomedical conditions (e.g., cerebral palsy, autism spectrum disorder)
  • Hearing thresholds greater than 25 dB in one ear and greater than 50 dB in the other ear
  • Planned surgical intervention during the study period

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Outpatient Treatment

Duration - Up to 16 weeks

Participants receive ultrasound-aided articulation therapy, a motor-phonetic behavioral intervention enhanced with ultrasound visual biofeedback. The immediate treatment group starts therapy right away, while the waitlist control group begins after 4 weeks without treatment.

Multiple visits during treatment period

Follow-up

Duration - Up to 16 weeks from baseline

Participants are assessed on speech accuracy, intelligibility, quality of life, behavioral strengths and difficulties, and parental stress after treatment completion.

1 to 3 visits depending on group and assessments

Trial Site Locations

Total: 1 location

1

Hong Kong Children's Hospital and Child Assessment Centre of The Duchess of Kent Children's Hospital

Hong Kong, Hong Kong

Actively Recruiting

Loading map...

Research Team

O

Oi Yan Yoyo Yiu

How is the study designed?

Study Type

INTERVENTIONAL

Masking

DOUBLE

Allocation

RANDOMIZED

Model

CROSSOVER

Primary Purpose

TREATMENT

Number of Arms

2

Similar Trials

A Developmental Framework For Linking Phonological And Morph...

Developmental Language Disorder

Actively Recruiting

2 locations

AI-Assisted Treatment for Residual Speech Sound Disorders in...

Speech Sound Disorder

Actively Recruiting

1 location

Online Assessment and Enhancement of Auditory Perception for...

Speech Sound Disorder

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Published Research Related To This Trial

Speech Sound Disorder and Visual Biofeedback Intervention: A Preliminary Investigation of Treatment Intensity.

Elaine R Hitchcock, Michelle T Swartz, Melissa Lopez

https://pubmed.ncbi.nlm.nih.gov/30795023

Is High-Intensity Speech Intervention Better? A Comparison of High-Intensity Intervention Versus Low-Intensity Intervention in Children With a Cleft Palate.

Cassandra Alighieri, Kristiane Van Lierde, Anne-Sophie De Caesemaeker...

https://pubmed.ncbi.nlm.nih.gov/34433000

The retrospective acceptability of high intensity versus low intensity speech intervention in children with a cleft palate: A qualitative study from the parents' point of view using the Theoretical Framework of Acceptability.

Cassandra Alighieri, Kristiane Van Lierde, Heleen Cammu...

https://pubmed.ncbi.nlm.nih.gov/36189983

Protocol for SonoSpeech Cleft Pilot: a mixed-methods pilot randomized control trial of ultrasound visual biofeedback versus standard intervention for children with cleft lip and palate.

Joanne Cleland, Lisa Crampin, Linsay Campbell...

https://pubmed.ncbi.nlm.nih.gov/35477444